Quantification of antifibrillarin (anti-u3 rnp) antibodies: a new insight for patients with systemic sclerosis

HIGHLIGHTS

  • who: Audrey Benyamine and collaborators from the Aix Marseilles University (AMU), INSERM, INRA, C VN, Marseilles, France have published the article: Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis, in the Journal: (JOURNAL) of 24/Nov/2015
  • what: The authors aimed to assess the relevance of AFAs and their clinical association in SSc patients. The authors demonstrate __NEWPAGE__Diagnostics 2021 11 1064 2 of 10 the usefulness of quantifying AFAs in the immunological exploration of SSc especially when patients are seronegative for SSc conventional autoantibodies and display a typical . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?